Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Savannah R. Wolfe"'
Autor:
Cynthia R. Muller, Alexander T. Williams, Allyn M. Eaker, Cynthia Walser, Fernando Dos Santos, Clayton T. Cuddington, Savannah R. Wolfe, Andre F. Palmer, Pedro Cabrales
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 176, Iss , Pp 116789- (2024)
The widespread adoption of high-calorie, high-fat, high-sucrose diets (HFHSD) has become a global health concern, particularly due to their association with cardiovascular diseases and metabolic disorders. These comorbidities increase susceptibility
Externí odkaz:
https://doaj.org/article/b20cb5ee5fce46bfbb87368a929784a2
Autor:
Cynthia R. Muller, Alexander T. Williams, Cynthia Walser, Allyn M. Eaker, Jose Luis Sandoval, Clayton T. Cuddington, Savannah R. Wolfe, Andre F. Palmer, Pedro Cabrales
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract For the past thirty years, hemoglobin-based oxygen carriers (HBOCs) have been under development as a red blood cell substitute. Side-effects such as vasoconstriction, oxidative injury, and cardiac toxicity have prevented clinical approval of
Externí odkaz:
https://doaj.org/article/7392dcbf710e404e92a253d0ccde2b43
Autor:
Clayton T. Cuddington, Savannah R. Wolfe, Donald A. Belcher, Megan Allyn, Alisyn Greenfield, Xiangming Gu, Richard Hickey, Shuwei Lu, Tanmay Salvi, Andre F. Palmer
Publikováno v:
Biotechnology and bioengineeringREFERENCES. 119(12)
Polymerized human hemoglobin (PolyhHb) is being studied as a possible red blood cell (RBC) substitute for use in scenarios where blood is not available. While the oxygen (Osub2/sub) carrying capacity of PolyhHb makes it appealing as an Osub2/subthera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dcd2c97ed594a7e990c48282ce3de42
https://pubmed.ncbi.nlm.nih.gov/36120842
https://pubmed.ncbi.nlm.nih.gov/36120842
Autor:
Clayton Cuddington, Savannah R. Wolfe, Donald A. Belcher, Megan Allyn, Alisyn Greenfield, Xiangming Gu, Richard Hickey, Shuwei Lu, Andre Palmer
Polymerized human hemoglobin (PolyhHb) is being studied as a possible red blood cell (RBC) substitute for use in scenarios where blood is not available. While the O carrying capacity of PolyhHb makes it appealing as an O therapeutic, the commercial P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48f437e748381f7017d1f9d95e60db76
https://doi.org/10.22541/au.164600516.65619478/v1
https://doi.org/10.22541/au.164600516.65619478/v1
Autor:
Cynthia R, Muller, Alexander T, Williams, Cynthia, Walser, Allyn M, Eaker, Jose Luis, Sandoval, Clayton T, Cuddington, Savannah R, Wolfe, Andre F, Palmer, Pedro, Cabrales
Publikováno v:
Scientific reports. 12(1)
For the past thirty years, hemoglobin-based oxygen carriers (HBOCs) have been under development as a red blood cell substitute. Side-effects such as vasoconstriction, oxidative injury, and cardiac toxicity have prevented clinical approval of HBOCs. R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e1d74e797594400dd0eaade03987629c
https://pubmed.ncbi.nlm.nih.gov/36443351
https://pubmed.ncbi.nlm.nih.gov/36443351
Publikováno v:
Biotechnol Prog
Polymerized hemoglobin (Hb)-based oxygen carriers (HBOCs) are a scalable and cost-effective red blood cell (RBC) substitute. However, previous generations of commercial polymerized HBOCs elicited oxidative tissue injury in vivo due to the presence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e7020f44c86ee6858e6b14aaf02eac1
https://doi.org/10.1002/btpr.3219
https://doi.org/10.1002/btpr.3219
Publikováno v:
The FASEB Journal. 35
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::991000e096b5a2d8bb7a0391d2ed8700
https://doi.org/10.1096/fasebj.2021.35.s1.03598
https://doi.org/10.1096/fasebj.2021.35.s1.03598